Cannabis Company Names New Board Member
Cannabis Science -- a biotech company based in Irvine, CA specializing in the development of cannabinoid-based medicines -- has appointed Dr. Jermane Bond to its Scientific Advisory Board. The noted research scientist -- who earned his Master's from Fisk and Ph.D. from Howard University after graduating from Morehouse College -- has more than 15 years of research and public health experience and is expected to contribute significantly to the direction of Cannabis Science as it pertains to research, development, clinical translation, and collaborations. Bond is expected to aid in developing a transdisciplinary framework to address specific illnesses, integrating and extending discipline-based concepts and methods to advance treatment. He is currently an Assistant Research Professor at George Washington University and previously served as a Research Science Director for the Joint Center for Political and Economic Studies. The WSJ this week reported that entrepreneurs and investors are fueling the marijuana industry with a stock craze reminiscent of the late 1990s dot-com bubble and the recent bitcoin mania. Big companies, wealthy families, and amateurs alike are taking stakes in speculative companies, many of which have scant revenue or history, all to get a piece of what some economists say could sprout into a $100 billion annual business in the U.S. There has been a historic shift in public opinion for legalizing marijuana over the last generation. The racial disparity, however, hasn’t changed. Data shows that Blacks and Hispanics continue to be disproportionately arrested for marijuana-related charges compared to whites. And while business booms, there are still thousands of people of color who remain behind bars on marijuana charges that were brought before the public shifted their opinion. More here.